- Services
SERVICES
- Platform
PLATFORM
- Solutions
AI AGENTS
PHARMA & LIFE SCIENCES AI
TECHNOLOGY
- Industries
INDUSTRIES
- Work
- About Us
CORPORATE
RESOURCES
- Contact us
We enable Pharma and Life Sciences organizations transform complex, regulated workflows with enterprise AI. From regulatory affairs and safety to clinical, quality and commercial operations, at Wizr we design AI-powered solutions that automate processes, improve accuracy and accelerate decision-making with security, governance, traceability and optional human verification.
Transform quality and compliance operations with AI-powered workflows across deviations, CAPAs, batch records, SOPs, audits, inspections and validation. Automate manual processes, surface risks earlier and improve audit readiness while maintaining traceability and human oversight as required.
Batch record review across regulated life sciences manufacturing can be time-intensive and highly manual, consuming valuable Quality resources and creating potential release bottlenecks. Manual and semi-digital processes can also make it harder to identify out-of-trend patterns, detect errors early and maintain consistent quality oversight, resulting in costly investigations and delay.
Wizr brings AI-powered intelligence and automation to batch record review, helping Quality teams accelerate review, identify exceptions earlier and strengthen compliance, reducing the process from days to minutes.
The solution analyzes batch record entries to identify out-of-specification values, missing signatures and calculation discrepancies. AI agents continuously monitor parameters across batches to surface emerging trends and potential deviations, while generating draft investigation narratives for expert review and approval.
Cross-site analytics help identify recurring quality issues and systemic root causes, enabling faster investigations, stronger traceability and continuous improvement.
Expected Business Impact
CAPA (Corrective and Preventive Action) management remains a complex challenge across regulated pharma and life sciences organizations. Growing backlogs, inconsistent root cause analysis and time-intensive documentation can delay closure, increase compliance risk and make inspection readiness more difficult.
Wizr applies AI-powered intelligence and automation across the CAPA lifecycle – from investigation and root cause analysis to corrective actions, effectiveness checks and closure.
The solution analyzes historical deviations, complaints and CAPAs to identify potential root causes and surface supporting evidence. It draws on successfully closed CAPAs and institutional knowledge to recommend corrective actions, helping teams accelerate investigations and improve consistency across sites. Automated effectiveness checks monitor post-closure data for potential recurrence, while AI-assisted narratives help teams create consistent, audit-ready documentation with traceability to source deviations, risk classifications and applicable regulatory requirements.
Expected Business Impact
Wizr helps pharma and life sciences organizations modernize regulatory operations with AI-powered intelligence and automation. Continuously monitors global regulatory changes, assesses their impact across products and markets, and accelerates labeling, dossier updates and submission preparation with traceability, governance and human oversight built in.
For generic pharmaceutical companies, monitoring Reference Listed Drug (RLD) label changes across global regulatory sources is critical to maintaining labeling compliance. Every change across FDA DailyMed, EMA EPAR, PMDA, and 20+ other global regulatory portals must be continuously tracked and accurately reflected to maintain compliance and consistency. Manual monitoring can be time-intensive and makes it difficult for regulatory teams to quickly identify, assess and act on relevant changes.
Wizr automates regulatory surveillance and label-change intelligence across global health agencies.
AI-powered monitoring continuously scans regulatory sources (delivers alerts within 24 hours) for relevant label updates and identifies changes across indications, dosage, warnings, contraindications, adverse events and packaging. Regulatory teams receive a clear view of what changed, where it changed and the potential significance of each update.
This solution supports impact assessment across applicable products, markets and submissions, while maintaining a traceable record of detected changes, notifications and review decisions for audit and inspection readiness. Human review and approval remain embedded at defined control points, helping regulatory teams accelerate response while maintaining appropriate oversight.
Business Impact
In the fast-moving pharma and life sciences landscape, competitor approvals, indication expansions, label changes and regulatory milestones can quickly reshape development, regulatory and commercial strategies. Monitoring these developments across global markets is complex, particularly when information is fragmented across regulatory authorities, languages and data sources. For example: manually monitoring 20 to 50+ health authorities per therapy area is resource-intensive, making it difficult for teams to keep pace with critical approvals and regulatory updates across markets such as Japan, Brazil, and China.
Wizr brings intelligence and automation to global competitive and regulatory monitoring.
Continuously monitors regulatory sources across key markets to identify relevant competitor approvals, filings, indication expansions, label changes and other significant regulatory developments. AI-powered analysis translates and summarizes information from global sources, helping Regulatory, Commercial, Medical Affairs and Business Development teams access timely, consistent intelligence.
For priority products and therapeutic areas, intelligent alerts surface material developments as they occur. AI-assisted benchmarking helps teams compare competitor indications, labels and regulatory milestones against their own portfolios – supporting faster impact assessment and more informed strategic decisions. Human review and validation can be incorporated at defined control points, helping teams maintain confidence in critical regulatory and competitive intelligence.
Business Impact
Regulatory submissions are among the most complex and resource-intensive activities across pharma and life sciences. Preparing eCTD dossiers requires teams to coordinate large volumes of clinical, nonclinical, CMC and regulatory documentation while managing version control, regional requirements and rigorous technical validation. Drafting eCTD Modules 3 and 4 alone can require 16–20 weeks of experienced medical writer time per submission. Coordinating thousands of documents across Modules 1–5, maintaining version control across CROs and internal teams, and addressing market-specific requirements add significant complexity. Technical errors such as broken hyperlinks, incorrect file formats, or missing sections can result in a further 2–4 weeks of delay at the FDA or EMA gateway, when speed to approval matters most.
This solution from Wizr transforms eCTD preparation with AI-powered authoring, assembly and validation supported by human review and regulatory oversight throughout the submission lifecycle.
Specialized AI agents work across the eCTD workflow to author, collate, classify, cross-reference, validate, translate and assemble submission-ready dossiers. By drawing from existing source documents including clinical study reports, nonclinical summaries and CMC data, Wizr helps accelerate authoring while maintaining traceability to source content. Automated module assembly and pre-submission validation help identify missing files, broken hyperlinks, formatting issues and other potential technical errors before submission. AI-powered cross-reference checks further support consistency across tables, figures, citations and dossier modules.
Region-specific requirements and multilingual capabilities help teams prepare submissions across global markets, while configurable human-in-the-loop review ensures regulatory experts remain in control of critical decisions and final approvals.
Expected Business Impact
Our experts help pharma organizations modernize pharmacovigilance with AI-powered automation across safety case processing, adverse event monitoring, signal detection and regulatory reporting. Intelligent workflows reduce manual effort, accelerate safety operations and improve consistency while maintaining traceability, governance and human oversight.
Our experts help pharma and life sciences organizations accelerate compliant commercial execution with AI-powered content creation, MLR pre-review, claims validation, omnichannel intelligence and field enablement. Jurisdiction-aware controls, digital audit trails and real-time risk signals help teams accelerate content-to-market while maintaining regulatory and promotional compliance.
Wizr modernizes quality and compliance operations through AI-driven solutions for deviations, CAPAs, SOPs, audits, inspections, and validation. Intelligent workflows automate execution while maintaining full traceability, audit readiness, and risk visibility — with human review available at defined control points.
Wizr modernizes quality and compliance operations through AI-driven solutions for deviations, CAPAs, SOPs, audits, inspections, and validation. Intelligent workflows automate execution while maintaining full traceability, audit readiness, and risk visibility — with human review available at defined control points.
Wizr modernizes quality and compliance operations through AI-driven solutions for deviations, CAPAs, SOPs, audits, inspections, and validation. Intelligent workflows automate execution while maintaining full traceability, audit readiness, and risk visibility — with human review available at defined control points.
Wizr’s solutions incorporate configurable human-in-the-loop review and approval across regulatory, quality and safety-critical workflows, helping maintain accountability, compliance and confidence while accelerating automation.
Explore our case studies to see how Wizr is helping enterprises drive measurable transformation with AI.
Wizr delivers production-ready AI systems that automate operations, accelerate software delivery by more than 50%, and scale intelligence across the enterprise.
Let’s build yours!
